CLLS Earnings & Financial Statements
Cellectis S.A.
$1.12
+$0.02(+1.82%)
39
Overall
--
Value
36
Tech
42
Quality
Market Cap
$112.59M
Volume
99.08K
52W Range
$1.22 - $5.48
Target Price
$4.83
CLLS earnings and financial statements: Cellectis S.A.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CLLS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $6.64M | $7.71M | -$7.68M | $19.17M | $57.29M |
| Cost of revenue | -$72.95M | -$41.51M | $737.0K | -$1.77M | -$31.36M |
| Operating income | -$33.71M | -$60.40M | -$112.88M | -$115.41M | -$148.63M |
| EBITDA | $3.11M | $4.70M | -$71.58M | -$186.68M | -$222.74M |
| Net income | -$67.59M | -$36.76M | -$130.10M | -$326.58M | -$250.22M |
| EPS (diluted) | - | $-0.41 | $-1.77 | $-2.33 | $-2.55 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $324.72M | $383.55M | $334.27M | $261.22M | $382.08M |
| Total liabilities | $248.82M | $252.51M | $249.57M | -$334.97M | -$570.15M |
| Shareholders’ equity | $75.90M | $131.03M | $84.69M | $117.97M | $221.29M |
| Cash and equivalents | $61.53M | $143.25M | $81.71M | $89.79M | $185.64M |
| Long-term debt | $27.73M | $34.24M | $42.95M | $49.36M | $71.53M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$39.40M | $22.99M | -$24.75M | -$87.44M | -$104.56M |
| Capital expenditure | - | - | - | -$2.44M | -$19.74M |
| Free cash flow | -$42.93M | $19.15M | -$25.82M | -$89.89M | -$124.31M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLLS | $1.12 | +1.8% | 99.08K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |